35 studies found for:    " October 07, 2013":" November 06, 2013"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
Rank Status Study
21 Completed Pharmacokinetic Drug-drug Interaction Study Between RaltEgravir and CITALopram in Healthy Subjects (RECITAL).
Conditions: HIV;   Depression
Interventions: Drug: raltegravir;   Drug: citalopram
22 Recruiting A Phase I Trial to Assess the Safety of Tenofovir Gel and Film Formulations: FAME 04
Condition: HIV
Interventions: Drug: 1% vaginally applied tenofovir gel;   Drug: Tenofovir film- 10mg;   Drug: Tenofovir Film-40 mg
23 Active, not recruiting Modified Directly Observed Antiretroviral Therapy
Condition: HIV
Intervention: Other: Home visits
24 Active, not recruiting Adherence to HIV Therapy in Heroin Addicts: Oral vs. Extended Release Naltrexone
Condition: HIV+
Interventions: Drug: Oral naltrexone;   Drug: Naltrexone implant
25 Active, not recruiting Safety, Tolerability, Drug Interactions, and Antiviral Activity of Rilpivirine in Antiretroviral-Naive HIV-Infected Children Less Than 12 Years of Age
Condition: HIV Infections
Intervention: Drug: Rilpivirine
26 Withdrawn Evaluating the Safety and Immune Response to Three Different Prime-Boost HIV Vaccine Regimens in Healthy, HIV-Uninfected Adults
Condition: HIV Infections
Interventions: Biological: DNA Nat-B env vaccine;   Biological: NYVAC Nat-B env vaccine;   Biological: DNA CON-S env vaccine;   Biological: NYVAC CON-S env vaccine;   Biological: DNA Mosaic env vaccine;   Biological: NYVAC Mosaic env vaccine;   Biological: Placebo;   Device: Biojector 2000® Needle-Free Injection Management System™ (Biojector 2000®)
27 Not yet recruiting Evaluating the Safety and Immune Response to Five Different Combinations of HIV Vaccines in Healthy, HIV-Uninfected Adults
Condition: HIV Infections
Interventions: Biological: DNA-HIV-PT123;   Biological: NYVAC-HIV-PT1;   Biological: NYVAC-HIV-PT4;   Biological: AIDSVAX B/E®;   Biological: Placebo vaccine
28 Recruiting Implementation of the Pre-Exposure Prophylaxis (PrEP) to HIV: A Demonstrative Project.
Conditions: Prevention and Control;   Preventive Measures;   Preventive Therapy;   Prophylaxis;   HIV Not Infected Subjects
Intervention: Drug: emtricitabine (FTC) / tenofovir (TDF)
29 Recruiting Compare the Efficacy and Safety of Raltegravir Versus Efavirenz Combination Therapy in Treatment-naïve HIV-1 Patients
Condition: HIV-1 Infection
Interventions: Drug: Raltegravir;   Drug: Efavirenz
30 Recruiting Analysis of Host Genetic Factors in the Occurrence of Anemia and on the Virological Response to a Peg-interferon/Ribavirin Therapy in HIV-HCV Co-infected Patients
Condition: HIV-HCV Co-infected Patients
Intervention: Genetic: blood samples
31 Active, not recruiting A Trial of Radiofrequency Ablation for Anal Intraepithelial Neopplasia Using the HALO Ablation System
Condition: HIV-negative Subjects With Intra-anal Intraepithelial Neoplasia Containing High-grade Squamous Intraepithelial Lesions.
Intervention: Device: Radiofrequency Ablation (RFA) using the HALO Ablation System
32 Not yet recruiting Pharmacokinetics and Pharmacodynamics of the Etonogestrel Contraceptive Implant When Co-administered With Efavirenz
Condition: Drug Interaction
Intervention: Drug: Efavirenz
33 Completed Safety and Immunogenicity Study of AERAS-456 Vaccine for Tuberculosis
Conditions: Latent Tuberculosis;   Latent Tuberculosis Bacteriology and Histology Unknown
Intervention: Biological: Aeras-456
34 Completed
Has Results
Rapid, Minimally-invasive Voluntary Adult Male Circumcision
Condition: Circumcision
Interventions: Procedure: Surgical Control;   Procedure: Unicirc with tissue adhesive
35 Completed Multi-Level HIV Prevention for Pregnant Drug Abusers
Condition: Substance Related Disorders
Intervention: Behavioral: Enhanced Behavioral Skills Training

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-35) Next Page   
Indicates status has not been verified in more than two years